Medium-to-long term outcomes of bioresorbable scaffold treatment in patients with acute coronary syndrome
In low- to intermediate-risk ACS patients, those who got BRS had their first major heart event sooner than those who got DES. BRS is more tissue-friendly, yet over three years both groups had about the same amount of problems - only a few BRS patients still saw the scaffold collapse or the vessel slowly block.
Authors
- Mo-Wei Kong (ORCID: https://orcid.org/0000-0002-1214-164X)
- Jun Li (ORCID: https://orcid.org/0000-0001-9121-6162)
- Jie Zhang (ORCID: https://orcid.org/0000-0001-6717-4118)
- Xinrui Li (ORCID: https://orcid.org/0000-0001-7158-4785)
Institutions
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- World Journal of Cardiology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.4330/wjc.v17.i11.109287
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00